Diphemanil metilsulfate
Diphemanil Metilsulfate is a quaternary ammonium compound used primarily as an anticholinergic agent. It is commonly employed in the treatment of gastrointestinal disorders and hyperhidrosis.
Pharmacology[edit]
Diphemanil Metilsulfate functions by inhibiting the action of acetylcholine on muscarinic receptors. This action reduces the secretions of various exocrine glands and decreases the motility of the gastrointestinal tract.
Mechanism of Action[edit]
The compound acts as a competitive antagonist at muscarinic receptors, which are part of the parasympathetic nervous system. By blocking these receptors, Diphemanil Metilsulfate reduces the effects of parasympathetic stimulation, leading to decreased glandular secretions and reduced smooth muscle contractions.
Clinical Uses[edit]
Diphemanil Metilsulfate is used in the management of several conditions:
- Hyperhidrosis: It helps in reducing excessive sweating by inhibiting sweat gland activity.
- Peptic ulcer disease: The drug decreases gastric acid secretion, providing relief from ulcer symptoms.
- Irritable bowel syndrome (IBS): It alleviates symptoms by reducing intestinal motility and secretions.
Side Effects[edit]
Common side effects of Diphemanil Metilsulfate include:
These side effects are typical of anticholinergic agents due to their action on muscarinic receptors.
Contraindications[edit]
Diphemanil Metilsulfate should not be used in patients with:
Related Pages[edit]
| Pharmacology | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
